Compare VYNE & LMFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VYNE | LMFA |
|---|---|---|
| Founded | 2003 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 10.6M |
| IPO Year | 2018 | 2015 |
| Metric | VYNE | LMFA |
|---|---|---|
| Price | $0.41 | $0.88 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | ★ 892.9K | 639.3K |
| Earning Date | 11-06-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $524,000.00 | ★ $7,567,508.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16.67 | $17.20 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.29 | N/A |
| 52 Week Low | $0.28 | $0.75 |
| 52 Week High | $4.30 | $5.14 |
| Indicator | VYNE | LMFA |
|---|---|---|
| Relative Strength Index (RSI) | 61.95 | 42.49 |
| Support Level | $0.37 | $0.87 |
| Resistance Level | $0.39 | $0.97 |
| Average True Range (ATR) | 0.03 | 0.06 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 87.95 | 43.30 |
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.